Pyerin W
German Cancer Research Center, Heidelberg.
Adv Enzyme Regul. 1994;34:225-46. doi: 10.1016/0065-2571(94)90018-3.
Casein kinase II (CKII) is an ubiquitous Ser/Thr protein phosphotransferase in control of a variety of crucial cellular functions including metabolism, signal transduction, transcription, translation and replication. CKII levels are consistently higher in neoplastic tissues. The human CKII is composed of subunits alpha, alpha', and beta with molecular masses of 43, 38 and 28 kDa, respectively, that form heterotetrameric holoenzymes (alpha 2 beta 2; alpha alpha' beta 2, alpha'2 beta 2) showing autophosphorylation particularly at subunit beta and hence suspected to play a regulatory role. The amino acid sequences of subunits indicate high evolutionary conservation. Employing the complete set of tissue-derived (placenta) and recombinant (expressed in E. coli) subunits and CKII holoenzymes, the catalytic function of alpha and alpha' and the several-fold stimulation by beta is shown to occur comparably in tissue-derived and recombinant CKII and the autophosphorylation of beta is shown by site-directed mutagenesis to be not decisive for the tuning of CKII activity. The human genome contains two genes encoding CKII alpha. First, there is a processed (pseudo)gene which is 99% homologous to the CKII alpha cDNA and which possesses a promoter-like region adjacently upstream with TATA and CAAT boxes so that transcription cannot be excluded. Second, there is an active gene of which we have characterized so far a 18.9 kb long central fragment which contains 8 exons comprising bases 102-824 of the CKII alpha coding region. The gene fragment contains repetitive elements, most prominently 16 Alu repeats. The genome further contains one as yet uncharacterized CKII alpha' gene and one gene encoding CKII beta. The CKII beta gene has been characterized as a 4.2 kb spanning gene composed of seven exons which possesses three transcription start sites and the translation start site in the second exon. The first intron harbors an Alu repeat also. The promoter region of the CKII beta gene contains elements such as multiple GC boxes, a CpG island, and nonstandard-positioned CAAT boxes but lacks a TATA box thus characterizing the gene as a housekeeping gene. The CKII genes are not clustered at a certain chromosome but rather are distributed over the whole human genome. Using the genomic clones as the probes for in situ hybridization, the active CKII alpha gene was mapped to chromosome 20p13, the processed CKII alpha (pseudo)gene to chromosome 11p15, and the CKII beta gene to chromosome 6p21. (The CKII alpha' gene has been localized on chromosome 16 with a cDNA probe.).(ABSTRACT TRUNCATED AT 400 WORDS)
酪蛋白激酶II(CKII)是一种普遍存在的丝氨酸/苏氨酸蛋白磷酸转移酶,可控制多种关键的细胞功能,包括代谢、信号转导、转录、翻译和复制。在肿瘤组织中,CKII的水平一直较高。人CKII由α、α'和β亚基组成,分子量分别为43 kDa、38 kDa和28 kDa,它们形成异源四聚体全酶(α2β2;αα'β2,α'2β2),尤其在β亚基处显示出自身磷酸化,因此被怀疑发挥调节作用。亚基的氨基酸序列显示出高度的进化保守性。利用全套组织来源(胎盘)和重组(在大肠杆菌中表达)的亚基及CKII全酶,结果表明α和α'的催化功能以及β亚基带来的几倍刺激在组织来源和重组CKII中表现相当,并且通过定点诱变表明β亚基的自身磷酸化对CKII活性的调节并非决定性因素。人类基因组包含两个编码CKIIα的基因。首先,有一个加工过的(假)基因,它与CKIIα cDNA有99%的同源性,并且在其紧邻上游有一个类似启动子的区域,带有TATA盒和CAAT盒,因此不能排除转录的可能性。其次,有一个活性基因,到目前为止我们已经对其一个18.9 kb长的中央片段进行了表征,该片段包含8个外显子,涵盖CKIIα编码区的102 - 824个碱基。该基因片段包含重复元件,最显著的是16个Alu重复序列。基因组中还包含一个尚未表征的CKIIα'基因和一个编码CKIIβ的基因。CKIIβ基因已被表征为一个跨度为4.2 kb的基因,由7个外显子组成,有三个转录起始位点,翻译起始位点在第二个外显子中。第一个内含子中也含有一个Alu重复序列。CKIIβ基因的启动子区域包含多个GC盒、一个CpG岛和非标准定位的CAAT盒等元件,但缺乏TATA盒,因此该基因被表征为一个管家基因。CKII基因并非聚集在某一条染色体上,而是分布在整个人类基因组中。使用基因组克隆作为原位杂交的探针,活性CKIIα基因被定位到20号染色体p13区域,加工过的CKIIα(假)基因定位到11号染色体p15区域,CKIIβ基因定位到6号染色体p21区域。(CKIIα'基因已通过cDNA探针定位在16号染色体上。)(摘要截选至400字)